Evidence map›Paper›PMID 19444307›Full record

ReviewNature reviews. Immunology2009

Autoimmune T cell responses in the central nervous system.

Joan Goverman

Abstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 542 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
542citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

542 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Application of aptamers in regenerative medicine.Frontiers in bioengineering and biotechnology · 2022
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Fatigue and contributing factors in relapsing-remitting multiple sclerosis: a descriptive study based on the comprehensive fatigue assessment battery for multiple sclerosis (CFAB-MS).Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

482 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Joan GovermanDepartment of Immunology, University of Washington, Seattle, Washington 98195-7650, USA. goverman@u.washington.edu

Funding

MOG-Specific T Cell Trafficking in the Central Nervous SystemR01AI073726 · NIAID · UNIVERSITY OF WASHINGTON · PI GOVERMAN, JOAN M · 2008 to 2012
$2.0M
MECHANISMS OF TOLERANCE AND IMMUNITY TO CENTRAL NERVOUS SYSTEM ANTIGENSR01AI072737 · NIAID · UNIVERSITY OF WASHINGTON · PI GOVERMAN, JOAN M · 2007 to 2011
$1.9M
NIAID NIH HHS AI072737NIAID NIH HHS AI073726NIAID NIH HHS R01 AI072737NIAID NIH HHS R01 AI073726
6 · The paper itself

Abstract

Autoreactive T cell responses have a crucial role in central nervous system (CNS) diseases such as multiple sclerosis. Recent data indicate that CNS autoimmunity can be mediated by two distinct lineages of CD4+ T cells that are defined by the production of either interferon-gamma or interleukin-17. The activity of these CD4+ T cell subsets within the CNS influences the pathology and clinical course of disease. New animal models show that myelin-specific CD8+ T cells can also mediate CNS autoimmunity. This Review focuses on recent progress in delineating the pathogenic mechanisms, regulation and interplay between these different T cell subsets in CNS autoimmunity.

Indexed as

AnimalsAntigen-Presenting CellsAutoimmunityB-LymphocytesCentral Nervous SystemHumansInterferon-gammaInterleukin-17Multiple SclerosisMyelin SheathT-LymphocytesInterferon-gammaInterleukin-17

Identifiers

PMID19444307
PMCPMC2813731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.